Goal of Correction of Hyponatremia
The goal of correcting hyponatremia is to increase serum sodium by 4-6 mEq/L in 24 hours, not exceeding 8 mEq/L in 24 hours, to avoid osmotic demyelination syndrome while effectively treating symptoms. 1
Correction Rate Guidelines
Standard Correction Targets
- For most patients: 4-6 mEq/L in 24 hours 1
- Maximum safe correction: 8 mEq/L in 24 hours 1, 2
- For severe symptomatic hyponatremia: 4-6 mEq/L in first 1-2 hours using 3% hypertonic saline boluses 1
Special Considerations
- High-risk patients (severe malnutrition, alcoholism, advanced liver disease): Consider slower correction rates 2
- Advanced kidney disease patients: Require closer monitoring due to increased risk of osmotic demyelination syndrome 1
Monitoring During Correction
- Frequency: Monitor serum sodium every 4-6 hours during active correction 1
- Neurological assessment: Regular evaluation for signs of either worsening hyponatremia or osmotic demyelination syndrome 1
- Warning signs for overcorrection: If correction exceeds targets, treatment should be suspended 1
- Critical threshold: Suspend infusion if serum sodium exceeds 155 mEq/L 1
Risks of Inappropriate Correction
Too Slow Correction
- Recent evidence suggests that very slow correction (<4-6 mEq/L per 24 hours) is associated with increased mortality compared to more rapid correction 3
- May lead to persistent neurological symptoms and increased hospital length of stay 3
Too Rapid Correction
- Correction >12 mEq/L/24 hours can cause osmotic demyelination syndrome 2
- Symptoms include dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma, and death 2
- Osmotic demyelination typically presents 2-7 days after rapid correction 1
Treatment Strategies Based on Volume Status
Hypervolemic Hyponatremia
- Fluid restriction to 1,000-1,500 mL/day 1
- Consider albumin infusion for severe hyponatremia (<120 mEq/L) 1
- Diuretic therapy with spironolactone (starting at 100 mg, up to 400 mg) 1
Euvolemic Hyponatremia (SIADH)
- Fluid restriction, urea, or tolvaptan depending on severity and response 1
- Tolvaptan starting dose: 15 mg once daily, maximum 60 mg daily (not to exceed 30 days due to liver injury risk) 1, 2
- Alternative: Midodrine (7.5 mg three times daily) when vaptans unavailable 1
Hypovolemic Hyponatremia
- Normal saline infusion is recommended 1
Prevention of Complications
- Avoid fluid restriction during first 24 hours of tolvaptan therapy 2
- Hospital initiation of tolvaptan and other therapies that may rapidly correct sodium 2
- If overcorrection occurs, consider therapeutic relowering of serum sodium 4
- For patients at risk of water diuresis causing overcorrection, consider concurrent desmopressin administration with hypertonic saline 5
- Elevate head of bed to 30-degree angle if cerebral edema is present 1
Key Pitfalls to Avoid
- Inadvertent overcorrection is common and dangerous - have a clear correction plan and monitor frequently
- Failure to recognize high-risk patients who need slower correction rates
- Overly conservative correction may increase mortality in severely symptomatic patients
- Not adjusting therapy when correction is occurring too rapidly or too slowly
- Using tolvaptan for ADPKD - this is contraindicated due to hepatotoxicity risk 2
Remember that the goal of treatment is to safely correct sodium levels while preventing both the neurological complications of hyponatremia and the iatrogenic complications of treatment.